Posts Tagged "Parkinson’s"

Advanced Medicine with Dr. Rashid A. Buttar – April 30, 2018

Posted on Jul 23, 2018 in Autism, Vaccines

If you missed Advanced Medicine with Dr. Rashid A. Buttar and Robert Scott Bell, be sure to go to to listen to the show replay. Click Here to LISTEN NOW!   Get ready to learn things not traditionally taught to medical doctors! Some of the things you will hear Dr. Buttar and Robert talk about in this week’s show are: Latest CDC autism figures show 15 percent rise – Autism spectrum disorders (ASD) are conditions that affect development. They impact the ways a person interacts with other people and alter how they perceive the world. And, though every case...

Read More

New discoveries place lack of energy at the basis of Parkinson’s Disease

Posted on Apr 9, 2014 in Chronic Disease, Medical Rewind

Dr. Buttar and Robert Scott Bell discuss Parkinson’s on the March 24th Medical Rewind show…Hear what they have to say, listen to the show! Neuroscientists Vanessa Moraïs and Bart De Strooper from VIB and KU Leuven have demonstrated how a defect in the gene Pink1 results in Parkinson’s disease. By mapping this process at a molecular level, they have provided the ultimate proof that a deficient energy production process in cells can result in Parkinson’s disease. These insights are so revolutionary that they have been published in the leading journal Science. Vanessa...

Read More

Common amphetamine drugs linked to Parkinson's disease

Posted on Apr 22, 2011 in Uncategorized

Sunday, April 10, 2011 by: Jonathan Benson, staff writer   (NaturalNews) A new study to be presented at the 63rd Annual Meeting of the American Academy of Neurology says that users of amphetamine drugs like benzedrine and dexedrine have a heightened risk of developing Parkinson’s disease. According to a follow-up review of more than 66,000 volunteers who participated in the Multiphasic Health Checkup Cohort Exam between 1964 and 1973, users of amphetamines were 60 percent more likely than those who did not take the drugs to develop Parkinson’s. The drugs in question, which are...

Read More

Parkinson’s meds may trigger extreme behavior

Posted on May 3, 2009 in Chronic Disease

About 1 in 5 develops compulsive gambling or hypersexuality, study findsupdated 5:53 p.m. ET, Mon., April 13, 2009 NEW YORK – About one in five patients taking a therapeutic dose of a dopamine agonist, a class of drugs used to treat patients with Parkinson’s disease, may develop compulsive gambling or hypersexuality, according to a study of patients treated at the Mayo Clinic in Rochester, Minnesota. By contrast, these behaviors were not seen in untreated patients, those taking less than a therapeutic dose of a dopamine agonist, or patients receiving treatment with...

Read More


Posted on Sep 16, 2008 in Chronic Disease, Heavy Metals

For Immediate Release: Monday, September 16, 2008 The National Institute of Environmental Health Sciences (NIEHS), part of the National Institutes of Health (NIH), announced today that it will award three new grants totaling $21.25 million over a five-year period to study how environmental factors contribute to the cause, prevention and treatment of Parkinson’s disease and other related disorders. Parkinson’s disease is a neurodegenerative disorder that affects nerve cells, or neurons, in several parts of the brain, including neurons that use the chemical messenger dopamine to...

Read More